ZOTIDE ONE 600MCG INJECTION 2.4ML

Zotide One 600mcg injection 2.4ml includes the active ingredient in the form of Teriparatide. This is an artificial variant of the hormone parathyroid (PTH) created by the parathyroid glands. It is used to treat osteoporosis. Osteoporosis is a disease characterized by weak bones, increasing the risk of breaking. The risk of fractures caused by osteoporosis could significantly affect an individual’s well-being as they cause pain and hinder mobility. Zotide One 600mcg injection 2.4ml helps promote the growth of bone tissue and increases bone mineral density. This drug has been demonstrated to speed up the healing process of bone for those suffering from fractures. It encourages the development of callus, the bridge of bone that is formed as healing proceeds, which leads to a speedier and more effective recovery.
Patients who have a history of allergy or hypersensitivity or reaction to Zotide 600mcg injection 2.4ml and any other component are advised to avoid this drug. It is not recommended for people who have any history of skeletal malignancies such as osteosarcoma or patients with bone metastases. If the patient has undergone prior radiation therapy that affected the skeleton, treatment is not recommended due to the possibility of developing osteosarcoma.